Lateral Flow Assays Market by Application, Product, Technique and End-user - Global Forecast to 2025
February 24, 2021 08:58 ET
|
Research and Markets
Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker...
Lateral Flow Assays Market to Reach $13.85 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis and Forecasts by Meticulous Research®
February 04, 2021 07:19 ET
|
Meticulous Market Research Pvt. Ltd.
London, Feb. 04, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled “Lateral Flow Assays Market by Product (Kits, Readers), Technique (Sandwich, Competitive, Multiplex),...
Global Veterinary Diagnostics Markets Report 2020: What has been the Impact of COVID-19?
December 22, 2020 04:23 ET
|
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Veterinary Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Veterinary Diagnostics Market to Reach $5.38 Billion by 2027, Growing at a CAGR of 8.7% From 2020 With COVID-19 Impact - Meticulous Research® Analysis
December 03, 2020 06:57 ET
|
Meticulous Market Research Pvt. Ltd.
London, Dec. 03, 2020 (GLOBE NEWSWIRE) -- The development of rapid, accurate, and sensitive diagnostic methods for detecting pathogens is the basis for treating, controlling, and eradicating...
Zomedica to Focus on TRUFORMA™ Commercialization
January 23, 2020 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), announced today that it intends to focus on the final development and...
Zomedica Commences Final TRUFORMA™ Diagnostic Verification Study
October 31, 2019 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced today that it has...
Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference
September 03, 2019 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it...
Veterinary Diagnostics Market To Reach USD 5.2 billion By 2026 Growing at a CAGR of 9.2% | Market Expertz
August 27, 2019 11:44 ET
|
Reports and Data
New York, Aug. 27, 2019 (GLOBE NEWSWIRE) -- The Veterinary Diagnostics Market is estimated to reach the valuation of USD 5.2 billion by the year 2026. The industry is expected to deliver a CAGR of...
Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors
August 19, 2019 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical...
Zomedica Announces Second Quarter 2019 Financial Results
August 08, 2019 16:08 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...